CONCORD HC GP (02453) announced that on August 26, 2025, the Company's controlling shareholder (as defined in the Listing Rules) Beijing Taihecheng Medical Technology Limited (Beijing Taihecheng) agreed to pledge 35.6 million H-shares of the Company to Pudong Development Bank as beneficiary. This represents approximately 99.99% of the total number of shares directly held by Beijing Taihecheng in the Company. As of the date of this announcement, the H-shares pledged by Beijing Taihecheng collectively represent approximately 4.54% of the Company's total issued share capital. To the best knowledge of the directors, Pudong Development Bank is an independent third party to the Company and its connected persons.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。